Allogene Therapeutics saw the highest growth of 124% in patent filings in February and 199% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 56% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Allogene Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Allogene Therapeutics has been focused on protecting inventions in United States(US) with seven publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 33% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Allogene Therapeutics is filings its patents. Among the top granted patent authorities, Allogene Therapeutics has 33% of its grants in United States(US), 33% in Australia(AU) and 33% in Spain(ES).

Immatics and University of Pennsylvania could be the strongest competitors for Allogene Therapeutics

Patents related to cell & gene therapy and genomics lead Allogene Therapeutics's portfolio

Allogene Therapeutics has the highest number of patents in cell & gene therapy followed by, genomics and nanomedicine. For cell & gene therapy, nearly 43% of patents were filed and no patents were granted in Q1 2024.

Solid tumor related patents lead Allogene Therapeutics portfolio followed by viral infections, and leukemia

Allogene Therapeutics has highest number of patents in solid tumor followed by viral infections, leukemia, bone sarcoma, and melanoma.

For comprehensive analysis of Allogene Therapeutics's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.